Risk Assessment
"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 5 | 5 | | 1997 | 1 | 6 | 7 | | 1998 | 1 | 4 | 5 | | 1999 | 0 | 10 | 10 | | 2000 | 1 | 13 | 14 | | 2001 | 0 | 16 | 16 | | 2002 | 2 | 32 | 34 | | 2003 | 1 | 27 | 28 | | 2004 | 4 | 40 | 44 | | 2005 | 7 | 50 | 57 | | 2006 | 7 | 38 | 45 | | 2007 | 5 | 62 | 67 | | 2008 | 10 | 68 | 78 | | 2009 | 3 | 91 | 94 | | 2010 | 3 | 113 | 116 | | 2011 | 7 | 112 | 119 | | 2012 | 5 | 135 | 140 | | 2013 | 16 | 104 | 120 | | 2014 | 18 | 144 | 162 | | 2015 | 17 | 128 | 145 | | 2016 | 25 | 146 | 171 | | 2017 | 23 | 180 | 203 | | 2018 | 22 | 153 | 175 | | 2019 | 32 | 177 | 209 | | 2020 | 24 | 163 | 187 | | 2021 | 19 | 131 | 150 | | 2022 | 2 | 57 | 59 | | 2023 | 0 | 39 | 39 | | 2024 | 1 | 108 | 109 | | 2025 | 0 | 141 | 141 | | 2026 | 0 | 64 | 64 |
To return to the timeline, click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Guseh JS, Allen LA, Castelletti S, Baggish AL, Levine BD, Kim JH, Wilhelm M, Martinez MW. Task Force 5: Clinical Considerations for Myocarditis and Selected Cardiovascular Conditions, Including Valvular Heart Disease. Med Sci Sports Exerc. 2026 Dec 01; 58(12):2852-2859.
-
Leary JC, Tran N, Brittan MS, Fritz CQ, Lax Y, Lopez MA, Masciale M, Garg A, Gottlieb LM, Landrigan CP, Pantell MS. Social Risk Screening and Referrals in the Pediatric Inpatient Setting. Pediatrics. 2026 Nov 01; 158(5).
-
McGinnis T, Saxon DR. Approach to the patient with elevated lipoprotein(a). J Clin Endocrinol Metab. 2026 Oct 16; 111(11):3286-3295.
-
Kalra SS, Grilli CB, Coombes BJ, Armasu S, Upjohn DP, Egan JB, Chen Q, Tern C, Zhang C, Rose JA, Putman R, Mcdermott G, Hsieh YL, Bublitz ML, Carmona EM, Klee EW, Lazaridis KN, Lasky-Su J, Dudbridge F, Peljto AL, Schwartz DA, Silverman EK, Allen RJ, Olson J, Walker T, Wain LV, Zamora A, Zein JG, Hunninghake GM, Ortega VE, Moll M, Cho MH. Association of a polygenic risk score with diagnosis and outcomes in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2026 Oct 01; 212(10):2435-2444.
-
Prueitt RL, Olgun NS, Andrew PM, Hixon ML, Piatos P, Na Y, Hu J, Drury NL, Goodman JE. Systematic review of evidence regarding potential carcinogenic mechanisms of mancozeb and ethylene thiourea (ETU). Regul Toxicol Pharmacol. 2026 Dec; 172:106250.
-
Khan F, Stretz C, Lewis S, Chahien D, Goldstein E, Siegler JE, Lineback CM, Eklund K, Khasiyev F, Al Kasab S, Culbertson CJ, D'Souza M, Stamm B, Ro J, Kerrigan D, Sharma R, Aboul-Nour H, Nahab F, Omran SS, Linares G, Sehgal S, Melkumova E, Singh E, Zha AM, Thottempudi N, Mannion S, Van Coevering R, Chen L, Thompson SL, Thon JM, Penckofer M, Yu W, Qdais AA, Jillella D, Sloane KL, Dumitrascu OM, Conyers FG, Talat F, Glover PA, Kang J, Patel V, Aziz Y, Zubair A, de Havenon A, Porto CV, Bowman A, Shahrivari M, Brorson JR, Liebeskind DS, Nedelcu S, Ali H, Abdalwahab A, Kam W, Nguyen TN, Herpich F, Farroqui M, Rojas-Soto D, Yaghi S. Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0. J Am Heart Assoc. 2026 Sep 15; 15(18):e050182.
-
Loh WS, Rentas CM, Waits SA, Englesbe MJ, Sheetz KH. Temporal Declines in Accuracy of the Donor Risk Index for Liver Transplantation. J Surg Res. 2026 Oct; 326:1068-1074.
-
Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI. Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer. 2026 Nov; 73(11):e70639.
-
Moedt E, Ju W, Nair V, Bjornstad P, Kretzler M, Heerspink HJL. Novel protein biomarkers for risk stratification and personalized medicine. Nephrol Dial Transplant. 2026 Aug 25; 41(Supplement_2):ii50-ii58.
-
Hofstetter TB, Scheidat I, Mansfeldt C, Robinson SL, Sander M, Bürgmann H. Do Chemically Modified Oligonucleotide Therapeutics Require Environmental Risk Assessment? Environ Sci Technol. 2026 Aug 18; 60(32):22174-22185.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|